Thomas J. Oxley (born September 29, 1980) is the chief executive officer of Synchron and neurointerventionist at Mount Sinai Hospital in New York City. Trained as a vascular and interventional neurologist, he established the Vascular Bionics laboratory at the University of Melbourne and is currently co-head of this lab. Oxley is best known for founding Synchron, a company building next-generation brain computer interface solutions that has recently announced the first clinical data on a novel stent electrode (Stentrode) neural interface that is inserted through blood vessels. The company was initiated sometime after his cold-call to DARPA for funding, and has received substantial funding from the U.S. Defense Advanced Research Projects Agency (DARPA) and the Australian government to resear
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Thomas Oxley (neurologist) (en)
- 托马斯·奥克斯利 (zh)
|
rdfs:comment
| - 托马斯·J·奥克斯利 (1980年9月29日生)是Synchron公司首席执行官、纽约的神经介入专家。他学习过血管和介入神经科学,在墨尔本大学创办了血管仿生学实验室,并成为该实验室的负责人之一。Synchron是一家构建下一代脑机接口解决方案的公司,奥克斯利是公司的创立者,他从美国國防高等研究計劃署和澳大利亚政府申请了大量资金用于研究微创神经接口技术。 (zh)
- Thomas J. Oxley (born September 29, 1980) is the chief executive officer of Synchron and neurointerventionist at Mount Sinai Hospital in New York City. Trained as a vascular and interventional neurologist, he established the Vascular Bionics laboratory at the University of Melbourne and is currently co-head of this lab. Oxley is best known for founding Synchron, a company building next-generation brain computer interface solutions that has recently announced the first clinical data on a novel stent electrode (Stentrode) neural interface that is inserted through blood vessels. The company was initiated sometime after his cold-call to DARPA for funding, and has received substantial funding from the U.S. Defense Advanced Research Projects Agency (DARPA) and the Australian government to resear (en)
|
foaf:name
| |
foaf:homepage
| |
name
| |
birth place
| |
birth place
| |
birth date
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
work institutions
| - Synchron, Inc., University of Melbourne (en)
|
dbp:wikiPageUsesTemplate
| |
birth date
| |
caption
| |
education
| |
field
| |
known for
| - CEO, Synchron, Inc. (en)
- Interventional Neurologist (en)
|
profession
| - Neurointerventionalist, CEO (en)
|
website
| |
years active
| |
has abstract
| - Thomas J. Oxley (born September 29, 1980) is the chief executive officer of Synchron and neurointerventionist at Mount Sinai Hospital in New York City. Trained as a vascular and interventional neurologist, he established the Vascular Bionics laboratory at the University of Melbourne and is currently co-head of this lab. Oxley is best known for founding Synchron, a company building next-generation brain computer interface solutions that has recently announced the first clinical data on a novel stent electrode (Stentrode) neural interface that is inserted through blood vessels. The company was initiated sometime after his cold-call to DARPA for funding, and has received substantial funding from the U.S. Defense Advanced Research Projects Agency (DARPA) and the Australian government to research this minimally-invasive neural interface technology. (en)
- 托马斯·J·奥克斯利 (1980年9月29日生)是Synchron公司首席执行官、纽约的神经介入专家。他学习过血管和介入神经科学,在墨尔本大学创办了血管仿生学实验室,并成为该实验室的负责人之一。Synchron是一家构建下一代脑机接口解决方案的公司,奥克斯利是公司的创立者,他从美国國防高等研究計劃署和澳大利亚政府申请了大量资金用于研究微创神经接口技术。 (zh)
|
institution
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
active years start year
| |
education
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |